about
TERT gene harbors multiple variants associated with pancreatic cancer susceptibilityMaldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides.Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications.Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle.Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty.Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1Reproducibility in urine peptidome profiling using MALDI-TOF.TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children.Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia.A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial FibrillationBlood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus.Insights in the laboratory diagnosis of celiac disease.Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisInflammatory bowel diseases: from pathogenesis to laboratory testing.Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications.Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals.Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome.Helicobacter pylori infection in children and adults: a single pathogen but a different pathology.Interleukin 1β and tumor necrosis factor-α polymorphisms in autoimmune gastritis.Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model.PCA3 score of 20 could improve prostate cancer detection: results obtained on 734 Italian individuals.GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children.Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study.Population-specific association of genes for telomere-associated proteins with longevity in an Italian population.Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children.New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis.VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study.Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms.Quantitative PSA mRNA determination in blood: a biochemical tool for scoring localized prostate cancer.ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applicationsCEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer stagingEffect of cagA status on the sensitivity of enzyme immunoassay in diagnosing Helicobacter pylori-infected childrenAntigastric autoantibodies in Helicobacter pylori infection: role in gastric mucosal inflammationIncreased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphismsSerum antibodies anti-H. pylori and anti-CagA: a comparison between four different assaysA new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodiesMitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcomeIL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections
P50
Q28386653-2929DEC4-9E32-4629-9740-5DA494F0E57FQ31054028-631596E2-39F0-48D5-A58C-C5B4A61459F0Q33216778-239FDB18-53B5-4EEC-BA05-6EC64094B12DQ33351879-BF720F6C-3CA4-44F6-96D3-5525995358E2Q33441700-419F6E9A-32CC-4105-9ED4-EE3D003D5719Q34150640-D40E1B15-6F0A-4E2C-A37B-640A985DA35BQ34566554-06CD8EBA-F843-44C6-AE67-B85FF92026E5Q35131817-9D0FA344-A2D9-443C-A26E-C50F45880569Q35530393-A00C9A2C-6C97-435A-AD40-65E3BDBA3CC1Q35542563-A7DB1471-9AC5-48C4-8B4A-74BFC08B0C18Q35586754-92712AAE-BE49-4A0C-A189-337D2DC7393BQ35879764-E1F5ED18-7F85-4AD5-83BC-02DB47CFE7BBQ35938687-37B4CE21-2A54-4FF6-A1E7-A3CAA1E94372Q36560802-CB1E7B8F-23E6-4EB6-B3F2-258212E3BC4CQ37065161-D5724489-083C-41AB-996C-7671365D01C0Q38150989-B42830E8-AB80-4095-A1DF-1E9C6D11F335Q39690759-46A1398D-C248-442E-9B62-EE4E2AA57E38Q43073246-27F82D00-EF9E-4A1C-A715-082B06BAA58BQ44001939-3C8794B4-1A23-4840-9A8B-EEB7E0498BC1Q44326410-0B3175CB-5232-4CCE-9A67-7756B8C2B8DBQ44374384-D0247837-026D-4EBB-BFC9-144C508602E2Q44645371-51B669CE-912C-4AFF-9AB2-B1AB134A760CQ45369120-EF877F6B-AB59-44A0-A3D6-D6D18BEB5E9EQ46168549-894C1186-E636-4188-844A-CD0099019D44Q46802745-006598BB-9DB1-48F5-A0AF-FBFD216B9116Q51373775-CF11E31C-EAB9-4115-816D-D29B34A31E8CQ51437664-7B851D34-ADC5-4565-B7DF-9BF2A4FEB8F0Q51561673-C1D92DE6-FC6D-4B76-A2F0-20EE4CA04AE2Q51622508-DE0FDCAF-7C44-4ADC-96F6-8B835F6471EEQ54533319-911B1EF1-2F76-4CFB-AD52-EF7ABECFE06BQ54615312-71749FE8-14E5-4E8F-96D0-81AFD07DBA1CQ73178795-4526B424-2151-4533-A37B-C001563FEF41Q73236352-AE1416F1-A313-4298-A613-14ED53351FFFQ73270976-D3737DD5-EF33-4710-9B25-018542D28807Q73716638-4D13048E-57E8-4960-BEC3-20CB289B8835Q75371581-1C3722EA-7921-42D7-94A4-9606F834A800Q78024360-41FF30CC-B2BA-4566-9B1A-7A45CA130690Q79387098-A71AA28E-D8DC-4C03-B6C8-549F42B5B779Q80180564-864246FF-A1E2-4A93-BC09-145E1EC787ACQ80458225-D23B9469-FD5F-4291-9571-F2DFB9CD65BA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlo-Federico Zambon
@ast
Carlo-Federico Zambon
@en
Carlo-Federico Zambon
@es
Carlo-Federico Zambon
@nl
type
label
Carlo-Federico Zambon
@ast
Carlo-Federico Zambon
@en
Carlo-Federico Zambon
@es
Carlo-Federico Zambon
@nl
prefLabel
Carlo-Federico Zambon
@ast
Carlo-Federico Zambon
@en
Carlo-Federico Zambon
@es
Carlo-Federico Zambon
@nl
P106
P31
P496
0000-0002-4244-879X